Money & MarketsMore than half of US nursing homes are unprofitable—and it's about to get a lot worseUpdated February 10, 2023
LifestyleProactive policing begins harming Black people before they are even bornUpdated January 30, 2023
Money & MarketsWHO approves generic Paxlovid drug for covid treatment in low-income countriesUpdated January 3, 2023
Money & MarketsBioNTech is set to ship its first modular mRNA vaccine factory to RwandaUpdated January 3, 2023
Money & MarketsAfrica's official covid vaccination rates are about to go up by a lotUpdated December 28, 2022
Money & MarketsThe US may make anti-overdose drug naloxone available over the counter in 2024Updated December 27, 2022
Money & MarketsThe end of zero-covid pushed China's biggest funeral services stock up by 80%Updated December 27, 2022
Money & MarketsThe US is about to make opioid addiction treatment much easierUpdated December 21, 2022
Money & MarketsHealth insurance rates will rise faster in 2023 in these US statesUpdated December 19, 2022
Money & MarketsThe return of free at-home covid tests for US households is a quiet message from the White HouseUpdated December 17, 2022
Money & MarketsThe 8 countries that wanted Iran to stay on the UN's Commission on the Status of WomenUpdated December 14, 2022
Money & MarketsHow AbbVie denied Americans access to fair competition for HumiraUpdated December 14, 2022
Money & MarketsCVS was sued for using customer donations at checkout to fund a corporate philanthropy pledgeUpdated December 6, 2022
Money & MarketsNYC's new plan to forcibly hospitalize homeless people is a waste of taxpayer moneyUpdated December 4, 2022
Money & MarketsHow to remove Iran from the UN Commission on the Status of WomenUpdated November 30, 2022
Money & MarketsIn Colombia, women’s health paid the price of misguided drug control policiesUpdated December 1, 2022
